FDA Psychiatry Digest: October 2026
Summary
Here’s a monthly snapshot of FDA activity involving therapies used in the prevention, diagnosis, and treatment of psychiatric conditions. Medscape Medical News
Description from Medscape.
Who is covering this
-
FDA Neurology Digest: October 2026
Here’s monthly snapshot of FDA activity involving therapies used in the prevention, diagnosis, and treatment of neurologic conditions.
-
FDA Psychiatry Digest: October 2026
Here’s a monthly snapshot of FDA activity involving therapies used in the prevention, diagnosis, and treatment of psychiatric conditions. Medscape Medical News
Related stories
Actor Ajay Devgn moves High Court against FDA notice over Vimal Elaichi ads
7 sourcesvia The HinduTruth score 731
FDA scientists opposed Trump administration’s move to ease peptide access
4 sourcesvia The GuardianTruth score 66
Blood pressure medication recalled nationwide
4 sourcesvia USA TODAYTruth score 671
Patanjali ghee among Rs 9 crore food stock seized in Maharashtra FDA crackdown
3 sourcesvia India TodayTruth score 54
Trump administration says biggest changes coming to infant formula in nearly 30 years
2 sourcesvia ABC News (US)Truth score 533
FDA issues alert about Northfield-based Medline beds tied to fire-related deaths and injuries
3 sourcesvia Chicago Sun-TimesTruth score 59
Comments
Comments need JavaScript.